Safety and Immune Response Study of an Investigational Pneumococcal Vaccine.

Clinical trial NCT00327522 · COMPLETED

Trial details

NCT number: NCT00327522
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prophylactic Pneumococcal Diseases

Start date: 2006-06-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.